DOI QR코드

DOI QR Code

Surgical Outcomes of Cervical Esophageal Cancer: A Single-Center Experience

  • Yoonseo Lee (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jeonghee Yun (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yeong Jeong Jeon (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Junghee Lee (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Seong Yong Park (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jong Ho Cho (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Hong Kwan Kim (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yong Soo Choi (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Young Mog Shim (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2023.07.04
  • Accepted : 2023.10.20
  • Published : 2024.01.05

Abstract

Background: Cervical esophageal cancer is a rare malignancy that requires specialized care. While definitive chemoradiation is the standard treatment approach, surgery remains a valuable option for certain patients. This study examined the surgical outcomes of patients with cervical esophageal cancer. Methods: The study involved a retrospective review and analysis of 24 patients with cervical esophageal cancer. These patients underwent surgical resection between September 1994 and December 2018. Results: The mean age of the patients was 61.0±10.2 years, and 22 (91.7%) of them were male. Furthermore, 21 patients (87.5%) had T3 or T4 tumors, and 11 (45.8%) exhibited lymph node metastasis. Gastric pull-up with esophagectomy was performed for 19 patients (79.2%), while 5 (20.8%) underwent free jejunal graft with cervical esophagectomy. The 30-day operative mortality rate was 8.3%. During the follow-up period, complications included leakage at the anastomotic site in 9 cases (37.5%) and graft necrosis of the gastric conduit in 1 case. Progression to oral feeding was achieved in 20 patients (83.3%). Fifteen patients (62.5%) displayed tumor recurrence. The median time from surgery to recurrence was 10.5 months, and the 1-year recurrence rate was 73.3%. The 1-year and 3-year survival rates were 75% and 33.3%, respectively, with a median survival period of 17 months. Conclusion: Patients with cervical esophageal cancer who underwent surgical resection faced unfavorable outcomes and relatively poor survival. The selection of cases and decision to proceed with surgery should be made cautiously, considering the risk of severe complications.

Keywords

References

  1. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 2006;135:451-7. https://doi.org/10.1016/j.otohns.2006.01.029 
  2. Lee DJ, Harris A, Gillette A, Munoz L, Kashima H. Carcinoma of the cervical esophagus: diagnosis, management, and results. South Med J 1984;77:1365-7. https://doi.org/10.1097/00007611-198411000-00004 
  3. Hoeben A, Polak J, Van De Voorde L, Hoebers F, Grabsch HI, de Vos-Geelen J. Cervical esophageal cancer: a gap in cancer knowledge. Ann Oncol 2016;27:1664-74. https://doi.org/10.1093/annonc/mdw183 
  4. Lam KH, Wong J, Lim ST, Ong GB. Pharyngogastric anastomosis following pharyngolaryngoesophagectomy: analysis of 157 cases. World J Surg 1981;5:509-16. https://doi.org/10.1007/BF01655003 
  5. Lam KH, Choi TK, Wei WI, Lau WF, Wong J. Present status of pharyngogastric anastomosis following pharyngolaryngo-oesophagectomy. Br J Surg 1987;74:122-5. https://doi.org/10.1002/bjs.1800740218 
  6. Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg 2011;35:600-7. https://doi.org/10.1007/s00268-010-0876-7 
  7. Ajani JA, D'Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17:855-83. https://doi.org/10.6004/jnccn.2019.0033 
  8. Du XX, Yu R, Wang ZF, et al. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy. Bosn J Basic Med Sci 2019;19:186-94. https://doi.org/10.17305/bjbms.2019.3873 
  9. Cohen C, Tessier W, Gronnier C, et al. Salvage surgery for esophageal cancer: how to improve outcomes? Ann Surg Oncol 2018;25:1277-86. https://doi.org/10.1245/s10434-018-6365-1 
  10. Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol 2017;12:36-42. https://doi.org/10.1016/j.jtho.2016.10.016 
  11. Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 2017;6:119-30. https://doi.org/10.21037/acs.2017.03.14 
  12. Lordick F, Mariette C, Haustermans K, Obermannova R, Arnold D; ESMO Guidelines Committee. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(suppl 5):v50-7. https://doi.org/10.1093/annonc/mdw329 
  13. Huang SH, Lockwood G, Brierley J, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys 2008;71:735-40. https://doi.org/10.1016/j.ijrobp.2007.10.022 
  14. Gkika E, Gauler T, Eberhardt W, Stahl M, Stuschke M, Pottgen C. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus 2014;27:678-84. https://doi.org/10.1111/dote.12146 
  15. Lee GD, Kim YH, Kim JB, et al. Esophageal cancer associated with multiple primary cancers: surgical approaches and long-term survival. Ann Surg Oncol 2013;20:4260-6. https://doi.org/10.1245/s10434-013-3183-3 
  16. Triboulet JP, Mariette C, Chevalier D, Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg 2001;136:1164-70. https://doi.org/10.1001/archsurg.136.10.1164 
  17. Daiko H, Hayashi R, Saikawa M, et al. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol 2007;96:166-72. https://doi.org/10.1002/jso.20795 
  18. Sun F, Li X, Lei D, et al. Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med 2014;7:2771-8. 
  19. Shiozaki H, Tsujinaka T, Inoue M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer: combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus 2000;13:213-8. https://doi.org/10.1046/j.1442-2050.2000.00114.x 
  20. Panhofer P, Springer C, Izay B, et al. Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction. Langenbecks Arch Surg 2013;398:221-30. https://doi.org/10.1007/s00423-012-0995-8 
  21. Miyata H, Yamasaki M, Takahashi T, et al. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg 2013;37:551-7. https://doi.org/10.1007/s00268-012-1875-7